Clinical and scientific advances made in the field of neuro-oncology

Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.

"Clearly, investigators in this field are innovative, and progress is being made on several fronts in understanding the molecular and cellular changes causal of nervous system neoplasm and developing new therapies," writes Roger N. Rosenberg, M.D., of the University of Texas Southwestern Medical Center, Dallas, and editor of the journal, in the editorial.

The theme issue focusing on cancers of the nervous system is being published in conjunction with a JAMA theme issue on cancer. The March issues of Archives of Pediatrics & Adolescent Medicine, Archives of Internal Medicine, Archives of Ophthalmology, Archives of Dermatology, Archives of Surgery, Archives of Facial Plastic Surgery and Archives of Otolaryngology-Head & Neck Surgery will also publish articles on this theme.

Articles in Archives of Neurology highlight the following topics, among others:
•Increased melanoma risk among Parkinson's disease patients
•Differences between brain tumors that cause seizures and those that do not
•Identifying cancer-related neurologic complications
•New insights into the risk of glioma, a brain or nervous system tumor
•New therapies for glioblastoma, a common and aggressive type of brain tumor
•Lymphoma in the central nervous system

"We are grateful to our colleagues for providing a rich and varied clinical and research experience with these articles to give a perspective and in-depth appreciation of the dynamic and vital development that the field of neuro-oncology has undergone in recent years," Dr. Rosenberg concludes. "The future looks positive and hopeful that continued progress will be made, especially in developing effective new therapies."
(Arch Neurol. 2010;67[3]:272. Available pre-embargo to the media at www.jamamedia.org.)

Source:

Archives of Neurology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Stand Up To Cancer partners with Johnson & Johnson to explore new treatment for AL amyloidosis